Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert L. Ruxer
Robert L. Ruxer
Texas Oncology
Internal medicine
Medicine
Gastroenterology
Surgery
Regimen
5
Papers
70
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma
2016
Clinical Colorectal Cancer
Daniel W. Bowles
Mark D. Kochenderfer
Allen Lee Cohn
Lucas Sideris
Nghia Nguyen
Vivian Jean Mikao Cline-Burkhardt
Ian Schnadig
Minsig Choi
Lisle Nabell
Arvind Chaudhry
Robert L. Ruxer
Antonio Ucar
Diana F. Hausman
Luke Walker
Alexander I. Spira
Antonio Jimeno
Show All
Source
Cite
Save
Citations (18)
Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial
2008
Journal of Thoracic Oncology
Mark A. Socinski
Robert N. Raju
Marcus A. Neubauer
David Smith
Donald A. Richards
Michael Savin
Robert L. Ruxer
Craig H. Reynolds
Feng Zhan
Jane L. Bromund
Ruqin Chen
Coleman K. Obasaju
Show All
Source
Cite
Save
Citations (25)
Phase I study of a 3-drug regimen of gemcitabine/cisplatin/pemetrexed in patients with metastatic transitional cell carcinoma of the urothelium
2008
Investigational New Drugs
Thomas E. Hutson
Svetislava J. Vukelja
Daniel Atienza
Sanjay Awasthi
Robert Delaune
Margaret Deutsch
Philip Y. Dien
Thomas F. Gregory
Michael Kolodziej
Joseph J. Muscato
Robert N. Raju
Robert L. Ruxer
Stephanie Mull
Des Ilegbodu
Karen Hood
Steven Nicol
William R. Berry
Show All
Source
Cite
Save
Citations (6)
1